The DOI matches its Crossref record; 479 of the 479 references it cites were found in a registry or an index.
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
Open accessAbstract
Summary The natural history of cirrhosis is characterised by an asymptomatic compensated phase followed by a decompensated phase, marked by the development of overt clinical signs, the most frequent of which are ascites, bleeding, encephalopathy, and jaundice. The following Clinical Practice Guidelines (CPGs) represent the first CPGs on the management of decompensated cirrhosis. In this context, the panel of experts, having emphasised the importance of initiating aetiologic treatment for any degree of hepatic disease at the earliest possible stage, extended its work to all the complications of cirrhosis, which had not been covered by the European Association for the Study of the Liver guidelines, namely: ascites, refractory ascites, hyponatremia, gastrointestinal bleeding, bacterial infections, acute kidney injury, hepatorenal syndrome, acute-on-chronic liver failure, relative adrenal failure, cirrhotic cardiomyopathy, hepatopulmonary syndrome, and porto-pulmonary hypertension. The panel of experts, produced these GPGs using evidence from PubMed and Cochrane database searches providing up to date guidance on the management of decompensated cirrhosis with the only purpose of improving clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 479
Piano, S., Fasolato, S., Salinas, F., Romano, A., Tonon, M., Morando, F., Cavallin, M., Gola, E., Sticca, A., Loregian, A., et al. (2016) · Hepatology · doi:10.1002/hep.27941 · Cited by 243
Self-citationWong, F., Sniderman, K., Liu, P., Allidina, Y., Sherman, M., & Blendis, L. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-11-199506010-00002 · Cited by 242
Restuccia, T., Ortega, R., Guevara, M., Ginès, P., Alessandria, C., Ozdogan, O., Navasa, M., Rimola, A., Garcia-Valdecasas, J. C., Arroyo, V., et al. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2003.09.019 · Cited by 242
Portopulmonary Hypertension: Survival and Prognostic Factors
Le Pavec, J., Souza, R., Herve, P., Lebrec, D., Savale, L., Tcherakian, C., Jaïs, X., Yaïci, A., Humbert, M., Simonneau, G., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200804-613oc · Cited by 241
β‐Blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta‐analysis
Senzolo, M., Cholongitas, E., Burra, P., Leandro, G., Thalheimer, U., Patch, D., & Burroughs, A. K. (2009) · Liver International · doi:10.1111/j.1478-3231.2009.02038.x · Cited by 241
Acute kidney injury in decompensated cirrhosis
Tsien, C. D., Rabie, R., & Wong, F. (2013) · Gut · doi:10.1136/gutjnl-2011-301255 · Cited by 241
Cazzaniga, M., Salerno, F., Pagnozzi, G., Dionigi, E., Visentin, S., Cirello, I., Meregaglia, D., & Nicolini, A. (2007) · Gut · doi:10.1136/gut.2006.102467 · Cited by 241
Hunter, J. D., & Doddi, M. (2010) · British Journal of Anaesthesia · doi:10.1093/bja/aep339 · Cited by 240
Villanueva, C., Piqueras, M., Aracil, C., Gómez, C., López-Balaguer, J. M., Gonzalez, B., Gallego, A., Torras, X., Soriano, G., Sáinz, S., et al. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.05.016 · Cited by 239
Self-citationCulture-Negative Neutrocytic Ascites: A Variant of Spontaneous Bacterial Peritonitis
Runyon, B. A., & Hoefs, J. C. (1984) · Hepatology · doi:10.1002/hep.1840040619 · Cited by 236
Spontaneous bacterial empyema in cirrhotic patients: A prospective study
Xiol, X., Castellví, J. M., Guardiola, J., Sesé, E., Castellote, J., Perelló, A., Cervantes, X., & Iborra, M. J. (1996) · Hepatology · doi:10.1002/hep.510230410 · Cited by 235
CONTINUOUS INTRAVENOUS INFUSION OF EPOPROSTENOL FOR THE TREATMENT OF PORTOPULMONARY HYPERTENSION1
Kuo, P. C., Johnson, L. B., Plotkin, J. S., Howell, C. D., Bartlett, S. T., & Rubin, L. J. (1997) · Transplantation · doi:10.1097/00007890-199702270-00020 · Cited by 234
Fagundes, C., Pépin, M.-N., Guevara, M., Barreto, R., Casals, G., Solà, E., Pereira, G., Rodríguez, E., Garcia, E., Prado, V., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.03.015 · Cited by 234
Sola-Vera, J., Miñana, J., Ricart, E., Planella, M., González, B., Torras, X., Rodríguez, J., Such, J., Pascual, S., Soriano, G., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50169 · Cited by 231
Party, A. A. W., Choudhury, A., Jindal, A., Maiwall, R., Sharma, M. K., Sharma, B. C., Pamecha, V., Mahtab, M., Rahman, S., Chawla, Y. K., et al. (2017) · Hepatology International · doi:10.1007/s12072-017-9816-z · Cited by 226
Uncovered Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites: A Meta-Analysis
D’Amico, G., Luca, A., Morabito, A., Miraglia, R., & D’amico, M. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.07.031 · Cited by 225
Seo, Y. S., Park, S. Y., Kim, M. Y., Kim, J. H., Park, J. Y., Yim, H. J., Jang, B. K., Kim, H. S., Hahn, T., Kim, B. I., et al. (2014) · Hepatology · doi:10.1002/hep.27006 · Cited by 220
Gordon, F. D., Anastopoulos, H. T., Crenshaw, W., Gilchrist, B., McEniff, N., Falchuk, K. R., LoCicero, J., Lewis, W. D., Jenkins, R. L., & Trey, C. (1997) · Hepatology · doi:10.1002/hep.510250611 · Cited by 219
Bellot, P., Garc´ıa-Paga´n, J. C., France´s, R., Abraldes, J. G., Navasa, M., Pe´rez-Mateo, M., Such, J., & Bosch, J. (2010) · Hepatology · doi:10.1002/hep.23918 · Cited by 219
Mishra, S. R., Sharma, B. C., Kumar, A., & Sarin, S. K. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.09.031 · Cited by 218
Sildenafil treatment for portopulmonary hypertension
Reichenberger, F., Voswinckel, R., Steveling, E., Enke, B., Kreckel, A., Olschewski, H., Grimminger, F., Seeger, W., & Ghofrani, H. A. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00030206 · Cited by 214
Krag, A., Wiest, R., Albillos, A., & Gluud, L. L. (2012) · Gut · doi:10.1136/gutjnl-2011-301348 · Cited by 213
Self-citationStadlbauer, V. P., Wright, G. A. K., Banaji, M., Mukhopadhya, A., Mookerjee, R., Moore, K., & Jalan, R. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.10.055 · Cited by 212
Self-citationKim, J. J., Tsukamoto, M. M., Mathur, A. K., Ghomri, Y. M., Hou, L. A., Sheibani, S., & Runyon, B. A. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.212 · Cited by 212
Cillo, U., Burra, P., Mazzaferro, V., Belli, L., Pinna, A. D., Spada, M., Nanni Costa, A., & Toniutto, P. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13408 · Cited by 211
Mathurin, P., Louvet, A., Duhamel, A., Nahon, P., Carbonell, N., Boursier, J., Anty, R., Diaz, E., Thabut, D., Moirand, R., et al. (2013) · JAMA · doi:10.1001/jama.2013.276300 · Cited by 210
Guevara, M., Terra, C., Nazar, A., Solà, E., Fernández, J., Pavesi, M., Arroyo, V., & Ginès, P. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.06.013 · Cited by 208
Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial
Arabi, Y. M., Aljumah, A., Dabbagh, O., Tamim, H. M., Rishu, A. H., Al-Abdulkareem, A., Knawy, B. A., Hajeer, A. H., Tamimi, W., & Cherfan, A. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.090707 · Cited by 207
Prevention of Gram-Negative Translocation Reduces the Severity of Hepatopulmonary Syndrome
Rabiller, A., Nunes, H., Lebrec, D., Tazi, K. A., Wartski, M., Dulmet, E., Libert, J.-M., Mougeot, C., Moreau, R., Mazmanian, M., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200201-027oc · Cited by 204
Survival and prognostic factors of cirrhotic patients with ascites: a study of 134 outpatients.
Salerno, F., Borroni, G., Moser, P., Badalamenti, S., Cassarà, L., Maggi, A. C., Fusini, M., & Cesana, B. M. (1993) · PubMed · Cited by 203
Antibiotic prophylaxis in cirrhosis: Good and bad
Fernández, J., Tandon, P., Mensa, J., & Garcia‐Tsao, G. (2016) · Hepatology · doi:10.1002/hep.28330 · Cited by 203
Improved Survival After Liver Transplantation in Patients with Hepatopulmonary Syndrome
Gupta, S., Castel, H., Rao, R. V., Picard, M., Lilly, L., Faughnan, M. E., & Pomier-Layrargues, G. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02822.x · Cited by 202
Shaheen, N. J., Stuart, E., Schmitz, S. M., Mitchell, K. L., Fried, M. W., Zacks, S., Russo, M. W., Galanko, J., & Shrestha, R. (2005) · Hepatology · doi:10.1002/hep.20593 · Cited by 201
Pulmonary Angiogenesis in a Rat Model of Hepatopulmonary Syndrome
Zhang, J., Luo, B., Tang, L., Wang, Y., Stockard, C. R., Kadish, I., Van Groen, T., Grizzle, W. E., Ponnazhagan, S., & Fallon, M. B. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.12.001 · Cited by 200
Bosentan therapy for portopulmonary hypertension
Hoeper, M. M., Halank, M., Marx, C., Hoeffken, G., Seyfarth, H. J., Schauer, J., Niedermeyer, J., & Winkler, J. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00080804 · Cited by 197
Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients
Pischke, S., Suneetha, P. V., Baechlein, C., Barg-Hock, H., Heim, A., Kamar, N., Schlue, J., Strassburg, C. P., Lehner, F., Raupach, R., et al. (2010) · Liver Transplantation · doi:10.1002/lt.21958 · Cited by 196
Wang, Q., Lv, Y., Bai, M., Wang, Z., Liu, H., He, C., Niu, J., Guo, W., Luo, B., Yin, Z., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.006 · Cited by 196
Thévenot, T., Bureau, C., Oberti, F., Anty, R., Louvet, A., Plessier, A., Rudler, M., Heurgué-Berlot, A., Rosa, I., Talbodec, N., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.11.017 · Cited by 195
Nadim, M. K., Kellum, J. A., Davenport, A., Wong, F., Davis, C., Pannu, N., Tolwani, A., Bellomo, R., & Genyk, Y. S. (2012) · Critical Care · doi:10.1186/cc11188 · Cited by 195
Londoño, M., Guevara, M., Rimola, A., Navasa, M., Taurà, P., Mas, A., García–Valdecasas, J.-C., Arroyo, V., & Ginès, P. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.017 · Cited by 195
Ginès, P., Wong, F., Watson, H., Milutinovic, S., Ruiz del Arbol, L., & Olteanu, D. (2008) · Hepatology · doi:10.1002/hep.22293 · Cited by 193
Self-citationEndoscopic screening for varices in cirrhotic patients: data from a national endoscopic database
Kovalak, M., Lake, J., Mattek, N., Eisen, G., Lieberman, D., & Zaman, A. (2007) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2006.08.023 · Cited by 193
Leithead, J. A., Rajoriya, N., Tehami, N., Hodson, J., Gunson, B. K., Tripathi, D., & Ferguson, J. W. (2015) · Gut · doi:10.1136/gutjnl-2013-306502 · Cited by 192
Dam, G., Vilstrup, H., Watson, H., & Jepsen, P. (2016) · Hepatology · doi:10.1002/hep.28737 · Cited by 190
A Central Role for CD68(+) Macrophages in Hepatopulmonary Syndrome: Reversal by Macrophage Depletion
Thenappan, T., Goel, A., Marsboom, G., Fang, Y.-H., Toth, P. T., Zhang, H. J., Kajimoto, H., Hong, Z., Paul, J., Wietholt, C., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201008-1303oc · Cited by 190
The Impact of Treatment of Portopulmonary Hypertension on Survival Following Liver Transplantation
Ashfaq, M., Chinnakotla, S., Rogers, L., Ausloos, K., Saadeh, S., Klintmalm, G. B., Ramsay, M., & Davis, G. L. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01701.x · Cited by 188
The challenges of multi-drug-resistance in hepatology
Fernández, J., Bert, F., & Nicolas-Chanoine, M.-H. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.08.006 · Cited by 187
Rabie, R. N., Cazzaniga, M., Salerno, F., & Wong, F. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.321 · Cited by 186
Repeated paracentesis and i.v. albumin infusion to treat ‘tense’ ascites in cirrhotic patients
Salerno, F., Badalamenti, S., Incerti, P., Tempini, S., Restelli, B., Bruno, S., Bellati, G., & Roffi, L. (1987) · Journal of Hepatology · doi:10.1016/s0168-8278(87)80067-3 · Cited by 185
Huonker, M., Schumacher, Y. O., Ochs, A., Sorichter, S., Keul, J., & Rössle, M. (1999) · Gut · doi:10.1136/gut.44.5.743 · Cited by 185
Finkenstedt, A., Nachbaur, K., Zoller, H., Joannidis, M., Pratschke, J., Graziadei, I. W., & Vogel, W. (2013) · Liver Transplantation · doi:10.1002/lt.23678 · Cited by 183
Severe haemorrhage following abdominal paracentesis for ascites in patients with liver disease
Pache, I., & Bilodeau, M. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02387.x · Cited by 183
The spectrum of renal lesions in patients with cirrhosis: a clinicopathological study
Trawalé, J.-M., Paradis, V., Rautou, P.-E., Francoz, C., Escolano, S., Sallée, M., Durand, F., Valla, D., Lebrec, D., & Moreau, R. (2010) · Liver International · doi:10.1111/j.1478-3231.2009.02182.x · Cited by 182
Self-citationSantos, J., Planas, R., Pardo, A., Durández, R., Cabré, E., Morillas, R. M., Granada, M. L., Jiménez, J. A., Quintero, E., & Gassull, M. A. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00188-0 · Cited by 181
Rimola, A., Salmerón, J. M., Clemente, G., Rodrigo, L., Obrador, A., Miranda, L. M., Guarner, C., Planas, R., Solá, R., Vargas, V., et al. (1995) · Hepatology · doi:10.1002/hep.1840210312 · Cited by 181
Huelin, P., Piano, S., Solà, E., Stanco, M., Solé, C., Moreira, R., Pose, E., Fasolato, S., Fabrellas, N., de Prada, G., et al. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.09.156 · Cited by 179
Self-citationRuíz-del-Árbol, L., Achécar, L., Serradilla, R., Rodríguez-Gandía, M. Á., Rivero, M., Garrido, E., & Natcher, J. J. (2013) · Hepatology · doi:10.1002/hep.26509 · Cited by 178
Experience with inhaled iloprost and bosentan in portopulmonary hypertension
Hoeper, M. M., Seyfarth, H. J., Hoeffken, G., Wirtz, H., Spiekerkoetter, E., Pletz, M. W., Welte, T., & Halank, M. (2007) · European Respiratory Journal · doi:10.1183/09031936.00032407 · Cited by 178
Siegerstetter, V., Deibert, P., Ochs, A., Olschewski, M., Blum, H. E., & Rössle, M. (2001) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200105000-00011 · Cited by 178
The MELD score in patients awaiting liver transplant: Strengths and weaknesses
Bernardi, M., Gitto, S., & Biselli, M. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.11.008 · Cited by 174
Self-citationMorando, F., Maresio, G., Piano, S., Fasolato, S., Cavallin, M., Romano, A., Rosi, S., Gola, E., Frigo, A. C., Stanco, M., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.03.010 · Cited by 172
Self-citationInfections complicating cirrhosis
Piano, S., Brocca, A., Mareso, S., & Angeli, P. (2018) · Liver International · doi:10.1111/liv.13645 · Cited by 171
Self-citationRicart, E., Soriano, G., Novella, M. T., Ortiz, J., Sàbat, M., Kolle, L., Solá-Vera, J., Miñana, J. M., Dedéu, J. M., Gómez, C., et al. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80221-4 · Cited by 170
Augustin, S., Muntaner, L., Altamirano, J. T., González, A., Saperas, E., Dot, J., Abu–Suboh, M., Armengol, J. R., Malagelada, J. R., Esteban, R., et al. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.08.011 · Cited by 169
Narahara, Y., Kanazawa, H., Fukuda, T., Matsushita, Y., Harimoto, H., Kidokoro, H., Katakura, T., Atsukawa, M., Taki, Y., Kimura, Y., et al. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-010-0282-9 · Cited by 168
Pockros, P. J., & Reynolds, T. B. (1986) · Gastroenterology · doi:10.1016/0016-5085(86)90249-0 · Cited by 168
Bai, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i10.2704 · Cited by 167
Terlipressin for hepatorenal syndrome
Gluud, L. L., Christensen, K., Christensen, E. I., & Krag, A. A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005162.pub3 · Cited by 166
Self-citationAlbillos, A., Bañares, R., González, M., Ripoll, C., González, R., Catalina, M., & Molinero, L.-M. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01191.x · Cited by 165
Hepatopulmonary syndrome: Favorable outcomes in the MELD exception era
Iyer, V. N., Swanson, K. L., Cartin-Ceba, R., Dierkhising, R. A., Rosen, C. B., Heimbach, J. K., Wiesner, R. H., & Krowka, M. J. (2013) · Hepatology · doi:10.1002/hep.26070 · Cited by 164
Albillos, A., Bañares, R., González, M., Catalina, M.-V., & Molinero, L.-M. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.06.005 · Cited by 164
Terg, R., Fassio, E., Guevara, M., Cartier, M., Longo, C., Lucero, R. S., Landeira, C., Romero, G., Domínguez, N., Muñoz, A., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.024 · Cited by 164
Adrenocortical function during septic shock
Bouachour, G., Tirot, P., Gouello, J. P., Mathieu, E., Vincent, J. F., & Alquier, P. (1995) · Intensive Care Medicine · doi:10.1007/bf02425155 · Cited by 164
Mishra, S. R., Chander Sharma, B., Kumar, A., & Sarin, S. K. (2010) · Gut · doi:10.1136/gut.2009.192039 · Cited by 161
Utility of Pulse Oximetry Screening for Hepatopulmonary Syndrome
Arguedas, M. R., Singh, H., Faulk, D. K., & Fallon, M. B. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.12.003 · Cited by 160
Li, H., Chen, L.-Y., Zhang, N.-N., Li, S.-T., Zeng, B., Pavesi, M., Amorós, À., Mookerjee, R. P., Xia, Q., Xue, F., et al. (2016) · Scientific Reports · doi:10.1038/srep25487 · Cited by 160
Self-citationBeta adrenergic blockade and decompensated cirrhosis
Reiberger, T., & Mandorfer, M. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.11.001 · Cited by 160
Dilutional Hyponatremia in Patients With Cirrhosis and Ascites
Porcel, A., Díaz, F., Rendón, P., Macías, M., Martín-Herrera, L., & Girón-González, J. A. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.3.323 · Cited by 158
Angeli, P., Fasolato, S., Mazza, E., Okolicsànyi, L., Maresio, G., Velo, E., Galioto, A., Salinas, F., D'Aquino, M., Sticca, A., et al. (2009) · Gut · doi:10.1136/gut.2008.176495 · Cited by 157
Self-citationKidney biomarkers in cirrhosis
Francoz, C., Nadim, M. K., & Durand, F. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.025 · Cited by 157
Self-citationFacciorusso, A., Chandar, A. K., Murad, M. H., Prokop, L. J., Muscatiello, N., Kamath, P. S., & Singh, S. (2016) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(16)30157-1 · Cited by 156
Nazar, A., Guevara, M., Sitges, M., Terra, C., Solà, E., Guigou, C., Arroyo, V., & Ginès, P. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.08.027 · Cited by 155
Acevedo, J., Fernández, J., Prado, V., Silva, A., Castro, M., Pavesi, M., Roca, D., Jiménez, W., Ginès, P., & Arroyo, V. (2013) · Hepatology · doi:10.1002/hep.26535 · Cited by 150
Inflammation and portal hypertension – The undiscovered country
Mehta, G., Gustot, T., Mookerjee, R. P., García‐Pagán, J. C., Fallon, M. B., Shah, V. H., Moreau, R., & Jalan, R. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.03.014 · Cited by 150
Self-citationHernández–Gea, V., Aracil, C., Colomo, A., Garupera, I., Poca, M., Torras, X., Miñana, J. M., Guarner, C., & Villanueva, C. (2012) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.456 · Cited by 149
Self-citationTolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis
Cárdenas, A., Ginès, P., Marotta, P., Czerwiec, F. S., Oyuang, J., Guevara, M., & Afdhal, N. H. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.08.020 · Cited by 149
Long-Term Follow-Up of Portopulmonary Hypertension
Fix, O. K., Bass, N. M., Marco, T. D., & Merriman, R. B. (2007) · Liver Transplantation · doi:10.1002/lt.21174 · Cited by 149
Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections
Piano, S. S., Bartoletti, M., Tonon, M., Baldassarre, M., Chies, G., Romano, A., Viale, P., Vettore, E., Domenicali, M., Stanco, M., et al. (2017) · Gut · doi:10.1136/gutjnl-2017-314324 · Cited by 149
Self-citationCirrhosis and muscle cramps: Evidence of a causal relationship
Angeli, P., Albino, G., Carraro, P., Pria, M. D., Merkel, C., Caregaro, L., Bei, E. D., Bortoluzzi, A., Plebani, M., & Gatta, A. (1996) · Hepatology · doi:10.1002/hep.510230211 · Cited by 148
Self-citationIncidence, predictors and outcomes of acute-on-chronic liver failure in outpatients with cirrhosis
Piano, S. S., Tonon, M., Vettore, E., Stanco, M., Pilutti, C., Romano, A., Mareso, S., Gambino, C. G., Brocca, A., Sticca, A., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.07.008 · Cited by 148
Self-citationModification of cardiac function in cirrhotic patients with and without ascites
Valeriano, V., Funaro, S., Lionetti, R., Riggio, O., Pulcinelli, G., Fiore, P., Masini, A., Castro, S., & Merli, M. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)02045-1 · Cited by 147
Amoxicillin–Clavulanate-Induced Liver Injury
Drug-Induced Liver Injury Network (DILIN), deLemos, A. S., Ghabril, M., Rockey, D. C., Gu, J., Barnhart, H. X., Fontana, R. J., Kleiner, D. E., & Bonkovsky, H. L. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4121-6 · Cited by 146
Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy
Wong, L. P., Blackley, M. P., Andreoni, K. A., Chin, H., Falk, R. J., & Klemmer, P. J. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00408.x · Cited by 143
Bernardi, M., Rubboli, A., Trevisani, F., Cancellieri, C., Ligabue, A., Baraldini, M., & Gasbarrini, A. (1991) · Journal of Hepatology · doi:10.1016/0168-8278(91)90940-d · Cited by 142
Self-citationKrag, A. A., M�ller, S., Henriksen, J. H., Holstein‐Rathlou, N., Larsen, F. S., & Bendtsen, F. (2007) · Hepatology · doi:10.1002/hep.21901 · Cited by 142
Self-citationGoldberg, D. S., Krok, K. L., Batra, S., Trotter, J. F., Kawut, S. M., & Fallon, M. B. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.005 · Cited by 141
Augustín, S., Altamirano, J., González, A., et al. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.173 · Cited by 141
Rudler, M., Cluzel, P., Corvec, T. L., Benosman, H., Rousseau, G., Poynard, T., & Thabut, D. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12934 · Cited by 141
Appenrodt, B., Grünhage, F., Gentemann, M., Thyssen, L., Sauerbruch, T., & Lammert, F. (2009) · Hepatology · doi:10.1002/hep.23440 · Cited by 140
Arafah, B. M., Nishiyama, F. J., Tlaygeh, H., & Hejal, R. B. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0181 · Cited by 139
Prowle, J. R., & Bellomo, R. (2015) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2015.01.007 · Cited by 138
Lebrec, D., Thabut, D., Oberti, F., Perarnau, J., Condat, B., Barraud, H., Saliba, F., Carbonell, N., Renard, P., Ramond, M.-J., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.040 · Cited by 137
Albillos, A., Lledó, J. L., Rossi, I., et al. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90586-3 · Cited by 136
Angeli, P., Volpin, R., Piovan, D., Bortoluzzi, A., Craighero, R., Bottaro, S., Finucci, G. F., Casiglia, E., Sticca, A., Toni, R. D., et al. (1998) · Hepatology · doi:10.1002/hep.510280407 · Cited by 136
Self-citationSafety and Efficacy of Ambrisentan for the Treatment of Portopulmonary Hypertension
Cartin‐Ceba, R., Swanson, K. L., Iyer, V., Wiesner, R. H., & Krowka, M. J. (2010) · CHEST Journal · doi:10.1378/chest.10-0574 · Cited by 136
Bellot, P., Welker, M., Soriano, G., von Schaewen, M., Appenrodt, B., Wiest, R., Whittaker, S., Tzonev, R., Handshiev, S., Verslype, C., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.12.020 · Cited by 135
PORTOPULMONARY HYPERTENSION AND THE LIVER TRANSPLANT CANDIDATE
Kuo, P. C., Plotkin, J. S., Gaine, S., Schroeder, R. A., Rustgi, V. K., Rubin, L. J., & Johnson, L. B. (1999) · Transplantation · doi:10.1097/00007890-199904270-00001 · Cited by 135
Adrenocortical dysfunction in liver disease: A systematic review
Fede, G., Spadaro, L., Tomaselli, T., Privitera, G., Germani, G., Tsochatzis, E. A., Thomas, M., Bouloux, P.-M. G., Burroughs, A. K., & Purrello, F. (2012) · Hepatology · doi:10.1002/hep.25573 · Cited by 134
Drugs plus ligation to prevent rebleeding in cirrhosis: an updated systematic review
Puente, Á., Hernández–Gea, V., Graupera, I., et al. (2013) · Liver International · doi:10.1111/liv.12452 · Cited by 133
Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta‐analysis
Deltenre, P., Mathurin, P., Dharancy, S., Moreau, R., Bulois, P., Henrion, J., Pruvot, F., Ernst, O., Paris, J.-C., & Lebrec, D. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01095.x · Cited by 132
Wong, F. S.-H., Watson, H., Gerbes, A. L., Vilstrup, H., Badalamenti, S., Bernardi, M., Ginès, P., & for the Satavaptan Investigators Group (2011) · Gut · doi:10.1136/gutjnl-2011-300157 · Cited by 130
Self-citationAnalysis of a Urinary Biomarker Panel for Clinical Outcomes Assessment in Cirrhosis
Ariza, X., Solà, E., Elia, C., Barreto, R., Moreira, R., Morales‐Ruiz, M., Graupera, I., Rodríguez, E., Huelin, P., Solé, C., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128145 · Cited by 129
Assessment of adrenal function in cirrhotic patients: Salivary cortisol should be preferred
Galbois, A., Rudler, M., Massard, J., Fulla, Y., Bennani, A., Bonnefont‐Rousselot, D., Thibault, V., Reignier, S., Bourrier, A., Poynard, T., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.01.026 · Cited by 128
Shah, N. K., Dhar, D. K., Mohamed, F. E. Z. A., Habtesion, A., Davies, N. A., Jover‐Cobos, M., Macnaughtan, J., Sharma, V., Damink, S. W. M. O., Mookerjee, R. P., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.11.024 · Cited by 127
Self-citationRegulation of heme oxygenase-1 by nitric oxide during hepatopulmonary syndrome
Carter, E. P., Hartsfield, C. L., Miyazono, M., Jakkula, M., Morris, K. G., & McMurtry, I. F. (2002) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00385.2001 · Cited by 125
Shah, N. K., Mohamed, F. E. Z. A., Jover‐Cobos, M., Macnaughtan, J., Davies, N. A., Moreau, R., Paradis, V., Moore, K. P., Mookerjee, R. P., & Jalan, R. (2012) · Liver International · doi:10.1111/liv.12047 · Cited by 124
Self-citationSoriano, G., Castellote, J., Álvarez, C., Girbau, A., Gordillo, J., Baliellas, C., Casas, M., Pons, C., Román, E. M., Maisterra, S., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.10.012 · Cited by 124
Bossen, L., Krag, A. A., Vilstrup, H., Watson, H., & Jepsen, P. (2015) · Hepatology · doi:10.1002/hep.28352 · Cited by 124
Self-citationThe mechanism of the initial natriuresis after transjugular intrahepatic portosystemic shunt
Wong, F. S.-H., Sniderman, K. W., LIU, P. P., et al. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9041252 · Cited by 122
Tandon, P., Abraldeṣ, J. G., Keough, A., Bastiampillai, R., Jayakumar, S., Carbonneau, M., Wong, E., Kao, D. H., Bain, V. G., & Ma, M. M. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.11.019 · Cited by 122
Krowka, M. J., Wiesner, R. H., & Heimbach, J. K. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.03.026 · Cited by 120
McPhail, M. J. W., Shawcross, D. L., Abeles, R. D., Chang, A., Patel, V., Lee, G. H., Abdulla, M., Sizer, E., Willars, C., Auzinger, G. M., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.08.041 · Cited by 120
Francoz, C., Nadim, M. K., Baron, A., Prié, D., Antoine, C., Belghiti, J., Valla, D. C., Moreau, R., & Durand, F. (2013) · Hepatology · doi:10.1002/hep.26704 · Cited by 120
Self-citationImpact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1
BOYER, T. D., Sanyal, A. J., García–Tsao, G., Regenstein, F., Rossaro, L., Appenrodt, B., Gülberg, V., Sigal, S. H., Bexon, A. S., & Teuber, P. (2011) · Liver Transplantation · doi:10.1002/lt.22395 · Cited by 119
Bureau, C., Métivier, S., D’Amico, M., Péron, J. M., Otal, P., García‐Pagán, J. C., Chabbert, V., Chagneau-Derrode, C., Procopeț, B., Rousseau, H., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.025 · Cited by 118
Hepatopulmonary Syndrome in Patients With Hypoxic Hepatitis
Fuhrmann, V., Madl, C., Mueller, C. A., Holzinger, U., Kitzberger, R., Funk, G., & Schenk, P. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.014 · Cited by 117
Plauth, M., Schütz, T., Buckendahl, D. P., Kreymann, G., Pirlich, M., Grüngreiff, S., Romaniuk, P., Ertl, S., Weiß, M.-L., & Lochs, H. H. (2003) · Journal of Hepatology · doi:10.1016/j.jhep.2003.10.011 · Cited by 117
Barreto, R., Elia, C., Solà, E., Moreira, R., Ariza, X., Rodríguez, E., Graupera, I., Alfaro, I., Morales‐Ruiz, M., Poch, E., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.02.023 · Cited by 117
Sampaio, F., Pimenta, J. M., Bettencourt, N., Fontes‐Carvalho, R., Silva, A. P., Valente, J. P. P., Bettencourt, P., Fraga, J., & Gama, V. (2013) · Liver International · doi:10.1111/liv.12187 · Cited by 116
Min, Y. W., Lim, K. S., Min, B., Gwak, G., Paik, Y., Choi, M. S., Lee, J., Kim, J. J., Koh, K. C., Paik, S. W., et al. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12875 · Cited by 115
Merli, M., Nicolini, G., Angeloni, S., Gentili, F., Attili, A. F., & Riggio, O. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.40246.x · Cited by 115
Efficacy, safety and pharmacokinetics of bosentan in portopulmonary hypertension
Savale, L., Magnier, R., Pavec, J. L., Jaïs, X., Montani, D., O’Callaghan, D. S., Humbert, M. J. C., Dingemanse, J., Simonneau, G., & Sitbon, O. (2012) · European Respiratory Journal · doi:10.1183/09031936.00117511 · Cited by 115
Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis
Narahara, Y., Kanazawa, H., Taki, Y., Kimura, Y., Atsukawa, M., Katakura, T., Kidokoro, H., Harimoto, H., Fukuda, T., Matsushita, Y., et al. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05873.x · Cited by 112
Angeli, P., Pria, M. D., Bei, E. D., Albino, G., Caregaro, L., Merkel, C., Ceolotto, G., & Gatta, A. (1994) · Hepatology · doi:10.1002/hep.1840190113 · Cited by 110
Self-citationBureau, C., Adebayo, D., de Rieu, M. C., Elkrief, L., Valla, D. C., Peck‐Radosavljevic, M., McCune, A., Vargas, V., Simón‐Talero, M., Córdoba, J., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.06.010 · Cited by 110
Self-citationTerlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis
Rodríguez, E., Elia, C., Solà, E., Barreto, R., Graupera, I., Andrealli, A., Pereira, G., Poca, M., Sánchez‐Delgado, J., Guevara, M., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.12.032 · Cited by 109
Midodrine in patients with cirrhosis and refractory or recurrent ascites: A randomized pilot study
Singh, V., Dhungana, S. P., Singh, B., et al. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.04.027 · Cited by 108
Pariente, E. A., Bataille, C., Bercoff, E., & Lebrec, D. (1985) · Gastroenterology · doi:10.1016/s0016-5085(85)80088-3 · Cited by 106
Raevens, S., Colle, I. O., Reyntjens, K. M. E. M., Geerts, A. M., Berrevoet, F. C., Rogiers, X., TROISI, R. I., Vlierberghe, H. V., & Pauw, M. D. (2013) · Liver Transplantation · doi:10.1002/lt.23649 · Cited by 106
Zhang, W., Xu, X., Kao, R. L. C., Mele, T. S., Kvietys, P. R., Martin, C. M., & Rui, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107639 · Cited by 106
Zhou, Y., QIAO, L., WU, J., Hu, H., & Xu, C.-P. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2002.02775.x · Cited by 106
Saab, S., Hernandez, J. C., Chi, A. C., & Tong, M. J. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.3 · Cited by 106
Angeli, P., & Ginès, P. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.06.024 · Cited by 106
Self-citationKang, S. H., Lee, Y. B., Lee, J., Nam, J. Y., Chang, Y. W., Cho, H., Yoo, J., Cho, Y. Y., Cho, E. J., Yu, S. J., et al. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14275 · Cited by 106
Elfert, A., Abo Ali, L., Soliman, S., Ibrahim, S., & Abd-Elsalam, S. (2016) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000724 · Cited by 105
Bernardi, M., Laffi, G., Salvagnini, M., Azzena, G., Bonato, S., Marra, F., Trevlsani, F., Gasbarrini, G., Naccarato, R., & Gentillni, P. (1993) · Liver International · doi:10.1111/j.1600-0676.1993.tb00624.x · Cited by 105
Self-citationSystematic review: pentoxifylline for the treatment of severe alcoholic hepatitis
Parker, R., Armstrong, M. J., Corbett, C., Rowe, I., & Houlihan, D. D. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12279 · Cited by 105
Puthumana, J., Ariza, X., Belcher, J. M., Graupera, I., Ginès, P., & Parikh, C. R. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.11.035 · Cited by 105
Genetic Risk Factors for Hepatopulmonary Syndrome in Patients With Advanced Liver Disease
Roberts, K. E., Kawut, S. M., Krowka, M. J., Brown, R. S., Trotter, J. F., Shah, V. H., Peter, I., Tighiouart, H., Mitra, N., Handorf, E. A., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.03.044 · Cited by 103
Tan, T. C. H., Chang, L., Woodward, A. J., McWhinney, B. C., Galligan, J., Macdonald, G. A., Cohen, J., & Venkatesh, B. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.05.020 · Cited by 102
Moreau, R., Valla, D. C., Durand‐Zaleski, I., et al. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01188.x · Cited by 101
Hyponatremic and hepatic encephalopathies: similarities, differences and coexistence
Córdoba, J., García‐Martínez, R., & Simón‐Talero, M. (2010) · Metabolic Brain Disease · doi:10.1007/s11011-010-9172-3 · Cited by 101
Zhang, J., Yang, W., Luo, B., Hu, B., Maheshwari, A., & Fallon, M. B. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.05.014 · Cited by 100
McCormick, P. A., Mistry, P. K., Kaye, G., Burroughs, A. K., & McIntyre, N. (1990) · Gut · doi:10.1136/gut.31.2.204 · Cited by 99
Bartoletti, M., Giannella, M., Lewis, R. E., Caraceni, P., Tedeschi, S., Paul, M., Schramm, C., Bruns, T., Merli, M., Cobos-Trigueros, N., et al. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.08.001 · Cited by 97
Self-citationOutcomes of patients with chest tube insertion for hepatic hydrothorax
Orman, E. S., & Lok, A. S.-F. (2009) · Hepatology International · doi:10.1007/s12072-009-9136-z · Cited by 96
Terg, R., Cobas, S. M., Fassio, E., Landeira, G., Ríos, B., Vasen, W., Abecasis, R., Ríos, H., & Guevara, M. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80008-2 · Cited by 95
Fernández‐Esparrach, G., Guevarra, M., Sort, P., et al. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80427-8 · Cited by 94
Bang, U. C., Benfield, T., Hyldstrup, L., Jensen, J. B., & Bendtsen, F. (2016) · Liver International · doi:10.1111/liv.13119 · Cited by 94
Clària, J., Kent, J. D., López‐Parra, M., Escolar, G., Ruíz-del-Árbol, L., Ginès, P., Jiménez, W., Vucelic, B. N., & Arroyo, V. (2005) · Hepatology · doi:10.1002/hep.20595 · Cited by 93
Diuretic treatment in decompensated cirrhosis and congestive heart failure: effect of posture.
Ring‐Larsen, H., Henriksen, J. H., Wilken, C., Clausen, J., Pals, H., & Christensen, N. J. (1986) · BMJ · doi:10.1136/bmj.292.6532.1351 · Cited by 92
Talwalkar, J. A., Swanson, K. L., Krowka, M. J., Andrews, J. C., & Kamath, P. S. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.053 · Cited by 92
Hollatz, T. J., Musat, A. I., Westphal, S., Decker, C., D’Alessandro, A. M., Keevil, J. G., Li, Z., & Runo, J. R. (2012) · Liver Transplantation · doi:10.1002/lt.23407 · Cited by 92
Gatta, A., Angeli, P., Caregaro, L., et al. (1991) · Hepatology · doi:10.1002/hep.1840140205 · Cited by 92
Self-citationTan, H. K., James, P. D., Sniderman, K. W., & Wong, F. S.-H. (2014) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12725 · Cited by 90
Effects of a single terlipressin administration on cardiac function and perfusion in cirrhosis
Krag, A. A., Bendtsen, F., Mortensen, C., Henriksen, J. H., & Møller, S. (2010) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32833a4822 · Cited by 90
Self-citationMcNeilly, A. D., Macfarlane, D. P., O’Flaherty, E., Livingstone, D. E. W., Mitić, T., McConnell, K. M. M., MacKenzie, S. M., Davies, E., Reynolds, R. M., Thiesson, H. C., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.10.037 · Cited by 90
Hepatorenal Disorders: Role of the Renin-Angiotensin-Aldosterone System
Bernardi, M., Trevisani, F., Gasbarrini, A., & Gasbarrini, G. (1994) · Seminars in Liver Disease · doi:10.1055/s-2007-1007295 · Cited by 89
Self-citationFree cortisol index as a surrogate marker for serum free cortisol
le Roux, C. W., Sivakumaran, S., Alaghband‐Zadeh, J., Dhillo, W. S., Kong, W. M., & Wheeler, M. J. (2002) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/000456302760042182 · Cited by 89
Keller, F., Heinze, H., Jochimsen, F., Paszfall, J., Schuppan, D., & Buttner, P. G. (1995) · Renal Failure · doi:10.3109/08860229509026250 · Cited by 87
Acute-on-Chronic Liver Failure: Definition, Diagnosis, and Clinical Characteristics
Jalan, R., & Arroyo, V. (2016) · Seminars in Liver Disease · doi:10.1055/s-0036-1583202 · Cited by 87
Pathogenesis of Hepatorenal Syndrome: Implications for Therapy
Durand, F., Graupera, I., Ginès, P., Olson, J. C., & Nadim, M. K. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.09.013 · Cited by 86
Sersté, T., Gustot, T., Rautou, P., Francoz, C., Njimi, H., Durand, F., Valla, D. C., Lebrec, D., & Moreau, R. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.03.018 · Cited by 86
Self-citationDhiman, R. K., Agrawal, S., Gupta, T., Duseja, A. K., & Chawla, Y. K. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i40.14934 · Cited by 85
Altraif, I., Handoo, F. A., Aljumah, A. A., Alalwan, A. M., Dafalla, M., Saeed, A. M., Alkhormi, A. M., Albekairy, A. K., & Tamim, H. (2010) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2010.09.043 · Cited by 85
Update on adrenal insufficiency in patients with liver cirrhosis
Trifan, A. V., Chiriac, S., & Stanciu, C. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i4.445 · Cited by 85
Morando, F., Rosi, S., Gola, E., Nardi, M., Piano, S. S., Fasolato, S., Stanco, M., Cavallin, M., Romano, A., Sticca, A., et al. (2014) · Liver International · doi:10.1111/liv.12583 · Cited by 84
Self-citationDefining Acute-on-Chronic Liver Failure: Will East and West Ever Meet?
Bajaj, J. S. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.04.024 · Cited by 84
Ditah, I. C. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i13.1797 · Cited by 84
Sepsis-Associated AKI: Epithelial Cell Dysfunction
Emlet, D. R., Shaw, A., & Kellum, J. A. (2015) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2015.01.009 · Cited by 83
Hung, H.-H., Chang, C. Y., Hou, M., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.021 · Cited by 82
Tubular site of renal sodium retention in ascitic liver cirrhosis evaluated by lithium clearance
Angeli, P., Gatta, A., Caregaro, L., et al. (1990) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1990.tb01800.x · Cited by 82
Self-citationWong, F. S.-H., Ginès, P., Watson, H., Horsmans, Y., Angeli, P., Gow, P. J., Minini, P., & Bernardi, M. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.02.036 · Cited by 82
Self-citationMerli, M., Lucidi, C., Gregorio, V. D., Lattanzi, B., Giannelli, V., Giusto, M., Farcomeni, A., Ceccarelli, G., Falcone, M., Riggio, O., et al. (2015) · Hepatology · doi:10.1002/hep.28332 · Cited by 80
Villanueva, C., Graupera, I., Aracil, C., Alvarado‐Tápias, E., Miñana, J. M., Puente, Á., Hernández–Gea, V., Ardèvol, A., Pavel, O., Colomo, A., et al. (2017) · Hepatology · doi:10.1002/hep.29056 · Cited by 80
Self-citationStampehl, M. R., Mann, D. L., Nguyen, J., Cota, F., Colmenares, C., & Dokainish, H. (2014) · Echocardiography · doi:10.1111/echo.12613 · Cited by 78
Wu, V., Ko, W., Chang, H., Chen, Y., Chen, Y.-W., Chen, Y.-M., Hu, F., Lin, Y., Tsai, H., & Wu, K. (2007) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2007.04.006 · Cited by 78
Staufer, K., Roedl, K., Kivaranovic, D., Drolz, A., Horvatits, T., Rasoul‐Rockenschaub, S., Zauner, C., Trauner, M. A., & Fuhrmann, V. (2017) · Liver International · doi:10.1111/liv.13389 · Cited by 78
Salt or no salt in the treatment of cirrhotic ascites: a randomised study.
Gauthier, A., Vg, L., Quinton, A., Michel, H., RUEFF, B., Descos, L., Durbec, J. P., Fermanian, J., & Lancrenon, S. (1986) · Gut · doi:10.1136/gut.27.6.705 · Cited by 77
Gerbes, A. L., Gülberg, V., Waggershauser, T., Holl, J., & Reiser, M. F. (1998) · Hepatology · doi:10.1002/hep.510280313 · Cited by 77
Bauer, T., Follo, A., Navasa, M., Vilà, J., Planas, R., Clemente, G., Vargas, V., Bory, F., Vaquer, P., & Rodés, J. (2002) · Digestive Diseases and Sciences · doi:10.1023/a:1015386901343 · Cited by 76
Angeli, P., Guarda, S., Fasolato, S., MIOLA, E., Craighero, R., Piccolo, F. D., Antona, C., Brollo, L., FRANCHIN, M., Cillo, U., et al. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02706.x · Cited by 75
Self-citationChen, Y., Chan, A. C. Y., Chan, S.-C., Chok, K., Sharr, W. W., Fung, J., Liu, J.-H., Zhen, Z., Sin, W. C., Lo, C., et al. (2015) · Journal of Cardiology · doi:10.1016/j.jjcc.2015.08.001 · Cited by 74
Predictors of Waitlist Mortality in Portopulmonary Hypertension
DuBrock, H. M., Goldberg, D. S., Sussman, N., Bartolome, S., Kadry, Z., Salgia, R. J., Mulligan, D. C., Kremers, W. K., Kawut, S. M., Krowka, M. J., et al. (2017) · Transplantation · doi:10.1097/tp.0000000000001666 · Cited by 74
Role of Albumin Treatment in Patients With Spontaneous Bacterial Peritonitis
Poca, M., Concepción, M., Casas, M., Álvarez–Urturi, C., Gordillo, J., Hernández–Gea, V., Román, E. M., Guarner, C., Gich, I. J., Soriano, G., et al. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.11.012 · Cited by 71
Shalimar, S., Kumar, D., Vadiraja, P. K., Nayak, B., Thakur, B., Das, P., Gupta, S. D., Panda, S. K., & Acharya, S. K. (2015) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13213 · Cited by 69
A randomized controlled trial of quinidine in the treatment of cirrhotic patients with muscle cramps
LEE, F., Lee, S.-D., Tsai, Y., Lai, K.-H., Chao, Y., Lin, H.-C., Wang, S.-S., & Lo, K. (1991) · Journal of Hepatology · doi:10.1016/0168-8278(91)90944-7 · Cited by 69
Antibiotic resistance in healthcare‐related and nosocomial spontaneous bacterial peritonitis
Lutz, P. L., Nischalke, H. D., Krämer, B., Goeser, F., Kaczmarek, D. J., Schlabe, S., Parčina, M., Nattermann, J., Hoerauf, A. M., Strassburg, C. P., et al. (2016) · European Journal of Clinical Investigation · doi:10.1111/eci.12701 · Cited by 69
Thévenot, T., Borot, S., Rémy-Martin, A., Sapin, R., Cervoni, J., Richou, C., Vanlemmens, C., Cléau, D., Muel, E., Minello, A., et al. (2011) · Liver International · doi:10.1111/j.1478-3231.2010.02431.x · Cited by 68
Cabrera, J. J., Falcón, L., Gorriz, E., Pardo, M. D., Granados, R., Quinones, A., & Maynar, M. (2001) · Gut · doi:10.1136/gut.48.3.384 · Cited by 68
Research works printed but not linked: 130
- Arroyo, 2007, Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome, J Hepatol, 46, 935, 10.1016/j.jhep.2007.02.001 · doi:10.1016/j.jhep.2007.02.001
- Alvarez, 2011, Long-term clinical course of decompensated alcoholic cirrhosis: a prospective study of 165 patients, J Clin Gastroenterol, 45, 906, 10.1097/MCG.0b013e3182284e13 · DOI
- Moreau, 2017, A randomized trial of 6-month norfloxacin therapy in patients with Child-Pugh class C cirrhosis, J Hepatol, 66, S1, 10.1016/S0168-8278(17)30264-7 · doi:10.1016/s0168-8278(17)30264-7
- Sola, 2017, Midodrine and albumin for prevention of complications of cirrhosis in patients in the waiting list for liver transplantation. A randomized, multicenter, double-blind, placebo-controlled trial, J Hepatol, 66, S11, 10.1016/S0168-8278(17)30285-4 · doi:10.1016/s0168-8278(17)30285-4
- Gerbes, 1991, Ascitic fluid analysis for the differentiation of malignancy-related and nonmalignant ascites. Proposal of a diagnostic sequence, Cancer, 68, 1808, 10.1002/1097-0142(19911015)68:8<1808::AID-CNCR2820680827>3.0.CO;2-6 · doi:10.1002/1097-0142(19911015)68:8<1808::aid-cncr2820680827>3.0.co;2-6
- Biselli, 2015, A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18, Liver Int, 35, 184, 10.1111/liv.12538 · doi:10.1111/liv.12538
- Lin, 2005, Should bleeding tendency deter abdominal paracentesis?, Dig Liver Dis, 37, 946, 10.1016/j.dld.2005.07.009 · doi:10.1016/j.dld.2005.07.009
- Cabrera, 1982, Aminoglycoside nephrotoxicity in cirrhosis. Value of urinary beta 2-microglobulin to discriminate functional renal failure from acute tubular damage, Gastroenterology, 82, 97, 10.1016/0016-5085(82)90129-9 · doi:10.1016/0016-5085(82)90129-9
- Guevara, 2004, Effects of contrast media on renal function in patients with cirrhosis: a prospective study, Hepatology, 40, 646, 10.1002/hep.20373 · doi:10.1002/hep.20373
- Saab, 2006, TIPS vs. paracentesis for cirrhotic patients with refractory ascites, Cochrane Database Syst Rev, CD004889
- Gaba, 2015, Survival benefit of TIPS vs. serial paracentesis in patients with refractory ascites: a single institution case-control propensity score analysis, Clin Radiol, 70, e51, 10.1016/j.crad.2015.02.002 · DOI
- Lenaerts, 2006, Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system, Hepatology, 44, 844, 10.1002/hep.21355 · doi:10.1002/hep.21355
- Singh, 2013, Midodrine and clonidine in patients with cirrhosis and refractory or recurrent ascites: a randomized pilot study, Am J Gastroenterol, 108, 560, 10.1038/ajg.2013.9 · doi:10.1038/ajg.2013.9
- Tandon, 2009, The effect of 1 month of therapy with midodrine, octreotide-LAR and albumin in refractory ascites: a pilot study, Liver Int, 29, 169, 10.1111/j.1478-3231.2008.01778.x · doi:10.1111/j.1478-3231.2008.01778.x
- Badillo, 2014, Hepatic hydrothorax. Clinical features, management, and outcomes in 77 patients and review of the literature, Medicine, 93, 135, 10.1097/MD.0000000000000025 · doi:10.1097/md.0000000000000025
- Garbuzenko, 2017, Hepatic hydrothorax: An update and review of the literature, World J Hepatol, 1197, 10.4254/wjh.v9.i31.1197 · doi:10.4254/wjh.v9.i31.1197
- Zenda, 1998, Detection of diaphragmatic defect as the cause of severe hepatic hydrothorax with magnetic resonance imaging, Am J Gastroenterol, 9, 2288, 10.1111/j.1572-0241.1998.00639.x · doi:10.1111/j.1572-0241.1998.00639.x
- Hewett, 2016, Diagnosis of isolated hepatic hydrothorax using peritoneal scintigraphy, Hepatology, 64, 1364, 10.1002/hep.28634 · doi:10.1002/hep.28634
- Alonso, 2010, Pleural effusion in liver disease, Semin Respir Crit Care Med, 31, 698, 10.1055/s-0030-1269829 · doi:10.1055/s-0030-1269829
- Xiol, 2005, Liver transplantation in patients with hepatic hydrothorax, Transpl Int, 18, 672, 10.1111/j.1432-2277.2005.00116.x · doi:10.1111/j.1432-2277.2005.00116.x
- Sersté, 2010, The impact of preoperative hepatic hydrothorax on the outcome of adult liver transplantation, Eur J Gastroenterol Hepatol, 22, 207, 10.1097/MEG.0b013e3283311140 · doi:10.1097/meg.0b013e3283311140
- Hou, 2016, Effectiveness and safety of pleurodesis for hepatic hydrothorax: A systematic review and meta-analysis, Dig Dis Sci, 61, 3321, 10.1007/s10620-016-4260-9 · doi:10.1007/s10620-016-4260-9
- Huang, 2016, Thoracoscopic mesh repair of diaphragmatic defects in hepatic hydrothorax: A 10-year experience, Ann Thorac Surg, 101, 1921, 10.1016/j.athoracsur.2015.11.023 · doi:10.1016/j.athoracsur.2015.11.023
- Cordoba, 2010, Hyponatremic and hepatic encephalopathies: similarities, differences and coexistence, Metab Brain Dis, 25, 73, 10.1007/s11011-010-9172-3 · DOI
- Garcia-Pagan, 2008, Review article: the modern management of portal hypertension–primary and secondary prophylaxis of variceal bleeding in cirrhotic patients, Aliment Pharmacol Ther, 28, 178, 10.1111/j.1365-2036.2008.03729.x · doi:10.1111/j.1365-2036.2008.03729.x
- Li, 2016, Carvedilol for portal hypertension in cirrhosis: systematic review with meta-analysis, BMJ Open, 6, e010902, 10.1136/bmjopen-2015-010902 · doi:10.1136/bmjopen-2015-010902
- Payance, 2016, Lack of clinical or haemodynamic rebound after abrupt interruption of beta-blockers in patients with cirrhosis, Aliment Pharmacol Ther, 43, 966, 10.1111/apt.13577 · doi:10.1111/apt.13577
- Villanueva, 2014, Optimizing general management of acute variceal bleeding in cirrhosis, Curr Hepatol Rep, 13, 198, 10.1007/s11901-014-0241-7 · doi:10.1007/s11901-014-0241-7
- Avgerinos, 1997, Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial, Lancet, 350, 1495, 10.1016/S0140-6736(97)05099-X · doi:10.1016/s0140-6736(97)05099-x
- Azam, 2012, Short course adjuvant terlipressin in acute variceal bleeding: a randomized double blind dummy controlled trial, J Hepatol, 56, 819, 10.1016/j.jhep.2011.11.019 · doi:10.1016/j.jhep.2011.11.019
- Rios Castellanos, 2015, Endoscopic injection of cyanoacrylate glue vs. other endoscopic procedures for acute bleeding gastric varices in people with portal hypertension, Cochrane Database Syst Rev, 5, CD010180
- Thuluvath, 2002, Portal Hypertensive gastropathy, Am J Gastroenterol, 97, 2973, 10.1111/j.1572-0241.2002.07094.x · doi:10.1111/j.1572-0241.2002.07094.x
- Yoshikawa, 1998, Effects of endoscopic variceal ligation on portal hypertensive gastropathy and gastric mucosal blood flow, Am J Gastroenterol, 93, 71, 10.1111/j.1572-0241.1998.071_c.x · doi:10.1111/j.1572-0241.1998.071_c.x
- Urrunaga, 2014, Portal hypertensive gastropathy and colopathy, Clin Liver Dis, 18, 389, 10.1016/j.cld.2014.01.008 · doi:10.1016/j.cld.2014.01.008
- Hosking, 1987, The role of propranolol in congestive gastropathy of portal hypertension, Hepatology, 7, 437, 10.1002/hep.1840070304 · doi:10.1002/hep.1840070304
- Ripoll, 2007, Treatment of gastropathy and gastric antral vascular ectasia in patients with portal hypertension, Curr Treat Options Gastroenterol, 10, 483, 10.1007/s11938-007-0048-5 · doi:10.1007/s11938-007-0048-5
- Kamath, 2000, Gastric Mucosal Responses to intrahepatic portosystemic shunting in patients with cirrhosis, Gastroenterology, 118, 905, 10.1016/S0016-5085(00)70176-4 · doi:10.1016/s0016-5085(00)70176-4
- Rios, 2015, Endoscopic injection of cyanoacrylate glue vs. other endoscopic procedures for acute bleeding gastric varices in people with portal hypertension, Cochrane Database Syst Rev, 5, CD010180
- Runyon, 2003, The evolution of ascitic fluid analysis in the diagnosis of spontaneous bacterial peritonitis. Runyon BA, Am J Gastroenterol, 98, 1675, 10.1111/j.1572-0241.2003.07600.x · doi:10.1111/j.1572-0241.2003.07600.x
- Gülberg, 2007, Insufficient sensitivity of reagent strips for spontaneous bacterial peritonitis, Hepatology, 46, 1669, 10.1002/hep.21856 · doi:10.1002/hep.21856
- Chen, 2011, Outcome predictors of cirrhotic patients with spontaneous bacterial empyema, Liver Int, 31, 417, 10.1111/j.1478-3231.2010.02447.x · doi:10.1111/j.1478-3231.2010.02447.x
- Garioud, 2017, J Clin Gastroenterol, 51, 831, 10.1097/MCG.0000000000000735 · doi:10.1097/mcg.0000000000000735
- Krag, 2010, Fluoroquinolones in the primary prophylaxis of spontaneous bacterial peritonitis, Am J Gastroenterol, 105, 1444, 10.1038/ajg.2010.126 · doi:10.1038/ajg.2010.126
- Arvaniti, 2010, Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis, Gastroenterology, 139, 1256, 10.1053/j.gastro.2010.06.019 · DOI · Paper page
- Fiore, 2017, Risk of spontaneousfungalperitonitis in hospitalized cirrhotic patients with ascites: a systematic review of observational studies and meta-analysis, Minerva Anestesiol, 83, 1309, 10.23736/S0375-9393.17.12034-1 · doi:10.23736/s0375-9393.17.12034-1
- Piano, 2017, Why and how to measure renal function in patients with liver disease, Liver Int, 37, 116, 10.1111/liv.13305 · doi:10.1111/liv.13305
- Roy, 1998, Glomerular filtration rate measurement in cirrhotic patients with renal failure, Clin Nephrol, 50, 342
- de Carvalho, 2012, Acute kidney injury network criteria as a predictor of hospital mortality in cirrhotic patients with ascites, J Clin Gastroenterol, 46, 21, 10.1097/MCG.0b013e31822e8e12 · doi:10.1097/mcg.0b013e31822e8e12
- 2012, Clinical practice guideline for the evaluation and management of chronic kidney disease, Kidny Int, 2013, 1
- Guevara, 2004, Effects of contrast media on renal function in patients with cirrhosis: a prospective study, Hepatology, 40, 646, 10.1002/hep.20373 · doi:10.1002/hep.20373
- Umgelter, 2009, Renal resistive index and renal function before and after paracentesis in patients with hepatorenal syndrome and tense ascites, Intensive Care Med, 35, 152, 10.1007/s00134-008-1253-y · doi:10.1007/s00134-008-1253-y
- Umgelter, 2008, Effects of plasma expansion with albumin and paracentesis on haemodynamics and kidney function in critically ill cirrhotic patients with tense ascites and hepatorenal syndrome: a prospective uncontrolled trial, Critical care, 12, R4, 10.1186/cc6765 · doi:10.1186/cc6765
- Qasem, 2014, Urinary biomarkers of acute kidney injury in patients with liver cirrhosis, ISRN Nephrol, 2014, 376795, 10.1155/2014/376795 · doi:10.1155/2014/376795
- Huelin, 2017, New diagnostic algorithm of acute kidney injury in cirrhosis that includes categorization of stage 1 and assessment of urine NGAL. Relevance for the differential diagnosis and clinical outcomes, J Hepatol, 66, S11, 10.1016/S0168-8278(17)30283-0 · doi:10.1016/s0168-8278(17)30283-0
- Wadei, 2008, Kidney allocation to liver transplant candidates with renal failure of undetermined etiology: role of percutaneous renal biopsy, Am J Transplant, 8, 2618, 10.1111/j.1600-6143.2008.02426.x · doi:10.1111/j.1600-6143.2008.02426.x
- Bairaktari, 2001, Partially reversible renal tubular damage in patients with obstructive jaundice, Hepatology, 33, 1365, 10.1053/jhep.2001.25089 · doi:10.1053/jhep.2001.25089
- van Slambrouck, 2013, Bile cast nephropathy is a common pathologic finding fo kidney injury associated with severe liver dysfunction, Kidney Int, 84, 192, 10.1038/ki.2013.78 · doi:10.1038/ki.2013.78
- Moreau, 2002, Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study, Gastroenterology, 122, 923, 10.1053/gast.2002.32364 · doi:10.1053/gast.2002.32364
- Gerbes, 2009, Terlipressin for hepatorenal syndrome: continuous infusion as an alternative to i.v. bolus administration, Gastroenterology, 137, 1179, 10.1053/j.gastro.2009.03.064 · doi:10.1053/j.gastro.2009.03.064
- Piano, 2011, Continuousrecurrenceof type 1 hepatorenal syndrome and long-term treatment with terlipressin and albumin: a new exception to MELD score in the allocation system to liver transplantation?, J Hepatol, 55, 491, 10.1016/j.jhep.2011.02.002 · doi:10.1016/j.jhep.2011.02.002
- Gow, 2016, Outpatient terlipressin infusion for the treatment of refractory ascites, Am J Gastroenterol, 111, 1041, 10.1038/ajg.2016.168 · doi:10.1038/ajg.2016.168
- Duvoux, 2002, Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study, Hepatology, 36, 374, 10.1053/jhep.2002.34343 · doi:10.1053/jhep.2002.34343
- Esrailian, 2007, Octreotide/Midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome, Dig Dis Sci, 52, 742, 10.1007/s10620-006-9312-0 · doi:10.1007/s10620-006-9312-0
- Brensing, 2000, Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study, Gut, 47, 288, 10.1136/gut.47.2.288 · doi:10.1136/gut.47.2.288
- Testino, 2003, Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation, Hepatogastroenterology, 50, 1753
- Sourianarayanane, 2014, Management and outcome in hepatorenal syndrome: need for renal replacement therapy in non-transplanted patients, Int Urol Nephrol, 46, 793, 10.1007/s11255-013-0527-7 · doi:10.1007/s11255-013-0527-7
- Trebicka, 2016, Predisposing factors in acute-on-chronic liver failure, Semin Liver Dis, 36, 167, 10.1055/s-0036-1583195 · doi:10.1055/s-0036-1583195
- Silva, 2015, Single-centre validation of the EASL-CLIF consortium definition of acute-on-chronic liver failure and CLIF-SOFA for prediction of mortality in cirrhosis, Liver Int, 35, 1516, 10.1111/liv.12597 · doi:10.1111/liv.12597
- Lee, 2015, CLIF-SOFA scoring system accurately predicts short-term mortality in acutely decompensated patients with alcoholic cirrhosis: a retrospective analysis, Liver Int, 35, 46, 10.1111/liv.12683 · DOI
- Chen, 2014, Dexamethasone in outcome of patients with hepatitis B virus-related acute-on-chronic liver failure, J Gastroenterol Hepatol, 29, 800, 10.1111/jgh.12454 · doi:10.1111/jgh.12454
- Guo, 2016, Short-term efficacy of treating hepatitis B virus-related acute-on-chronic liver failure based on cold pattern differentiation with hot herbs: A randomized controlled trial, Chin J Integr Med, 22, 573, 10.1007/s11655-016-2582-2 · doi:10.1007/s11655-016-2582-2
- De, 2003, Cardiac dysfunction in portal hypertension among patients with cirrhosis and non-cirrhotic portal fibrosis, J Hepatol, 39, 315, 10.1016/S0168-8278(03)00271-X · doi:10.1016/s0168-8278(03)00271-x
- Grose, 1995, Exercise-induced left ventricular dysfunction in alcoholic and non-alcoholic cirrhosis, J Hepatol, 22, 326, 10.1016/0168-8278(95)80286-X · doi:10.1016/0168-8278(95)80286-x
- Kim, 2010, Dobutamine stress echocardiography for evaluating cirrhotic cardiomyopathy in liver cirrhosis, Korean J Hepatol, 16, 376, 10.3350/kjhep.2010.16.4.376 · doi:10.3350/kjhep.2010.16.4.376
- Kozor, 2016, Insight into hypertrophied hearts: a cardiovascular magnetic resonance study of papillary muscle mass and T1 mapping, Eur Heart J Cardiovasc Imaging, 18, 1034, 10.1093/ehjci/jew187 · doi:10.1093/ehjci/jew187
- Ngu, 2016, Cardiac remodelling identified by cardiovascular magnetic resonance in patients with hepatitis C infection and liver disease, Int J Cardiovasc Imaging, 32, 629, 10.1007/s10554-015-0824-6 · doi:10.1007/s10554-015-0824-6
- Trevisani, 2012, QT interval prolongation by acute gastrointestinal bleeding in patients with cirrhosis, Liver Int, 32, 1510, 10.1111/j.1478-3231.2012.02847.x · doi:10.1111/j.1478-3231.2012.02847.x
- Zhao, 2016, Prevalence, risk factors and in-hospital outcomes of QTc interval prolongation in liver cirrhosis, Am J Med Sci, 352, 285, 10.1016/j.amjms.2016.06.012 · doi:10.1016/j.amjms.2016.06.012
- Raevens, 2014, Prevalence and outcome of diastolic dysfunction in liver transplantation recipients, Acta Cardiol, 69, 273, 10.1080/AC.69.3.3027830 · doi:10.1080/ac.69.3.3027830
- Saner, 2011, High brain-natriuretic peptide level predicts cirrhotic cardiomyopathy in liver transplant patients, Transpl Int, 24, 425, 10.1111/j.1432-2277.2011.01219.x · doi:10.1111/j.1432-2277.2011.01219.x
- Alexopoulou, 2012, Diastolic myocardial dysfunction does not affect survival in patients with cirrhosis, Transpl Int, 25, 1174, 10.1111/j.1432-2277.2012.01547.x · doi:10.1111/j.1432-2277.2012.01547.x
- Machicao, 2014, Pulmonary complications in chronic liver disease, Hepatology, 59, 1627, 10.1002/hep.26745 · doi:10.1002/hep.26745
- Kaymakoglu, 2003, Hepatopulmonary syndrome in noncirrhotic portal hypertensive patients, Dig Dis Sci, 48, 556, 10.1023/A:1022549018807 · doi:10.1023/a:1022549018807
- Rodríguez-Roisin, 1992, The hepatopulmonary syndrome: new name, old complexities, Thorax, 47, 897, 10.1136/thx.47.11.897 · doi:10.1136/thx.47.11.897
- Fallon, 2000, Pulmonary dysfunction in chronic liver disease, Hepatology, 32, 859, 10.1053/jhep.2000.7519 · doi:10.1053/jhep.2000.7519
- Schraufnagel, 2006, Structural and pathologic changes in the lung vasculature in chronic liver disease, Clin Chest Med, 17, 1, 10.1016/S0272-5231(05)70295-1 · doi:10.1016/s0272-5231(05)70295-1
- Boryczka, 2015, Influence of an upright body position on the size of intrapulmonary blood shunts in patients with advanced liver cirrhosis, J Physiol Pharmacol, 66, 855
- Fallon, 1997, The role of endothelial nitric oxide synthase in the pathogenesis of a rat model of hepatopulmonary syndrome, Gastroenterology, 113, 606, 10.1053/gast.1997.v113.pm9247483 · doi:10.1053/gast.1997.v113.pm9247483
- Luo, 2004, ET-1 and TNF- alpha in HPS: analysis in prehepatic portal hypertension and biliary and nonbiliary cirrhosis in rats, Am J Physiol Gastrointest Liver Physiol, 286, G294, 10.1152/ajpgi.00298.2003 · doi:10.1152/ajpgi.00298.2003
- Ling, 2004, The role of endothelin-1 and the endothelin B receptor in the pathogenesis of hepatopulmonary syndrome in the rat, Hepatology, 39, 1593, 10.1002/hep.20244 · doi:10.1002/hep.20244
- Tang, 2007, Modulation of pulmonary endothelial endothelin B receptor expression and signaling: implications for experimental hepatopulmonary syndrome, Am J Physiol Lung Cell Mol Physiol, 292, L1467, 10.1152/ajplung.00446.2006 · doi:10.1152/ajplung.00446.2006
- Frossard, 2007, Opposite regulation of endothelial NO synthase by HSP90 and caveolin in liver and lungs of rats with hepatopulmonary syndrome, Am J Physiol Gastrointest Liver Physiol, 293, G864, 10.1152/ajpgi.00136.2007 · doi:10.1152/ajpgi.00136.2007
- Chang, 2015, Rosuvastatin improves hepatopulmonary syndrome through inhibition of inflammatory angiogenesis of lung, Clin Sci, 129, 449, 10.1042/CS20140622 · doi:10.1042/cs20140622
- Rodriquez-Roisin, 2005, ERS (European Respiratory Society) Task ForcePHD Scientific Committee. Highlights of the ERS task force on pulmonary-hepatic vascular disorders (PHD), J Hepatol, 42, 924, 10.1016/j.jhep.2005.03.002 · doi:10.1016/j.jhep.2005.03.002
- Hoerning, 2014, Pulse oximetry is insufficient for timely diagnosis of hepatopulmonary syndrome in children with liver cirrhosis, J Pediatr, 164, 546, 10.1016/j.jpeds.2013.10.070 · doi:10.1016/j.jpeds.2013.10.070
- Köksal, 2006, Evaluation of intrapulmonary vascular dilatations with high-resolution computed thorax tomography in patients with hepatopulmonary syndrome, J Clin Gastroenterol, 40, 77, 10.1097/01.mcg.0000190775.57903.86 · doi:10.1097/01.mcg.0000190775.57903.86
- Lee, 1999, Hypoxemia and liver cirrhosis (hepatopulmonary syndrome) in eight patients: comparison of the central and peripheral pulmonary vasculature, Radiology, 211, 549, 10.1148/radiology.211.2.r99ma46549 · doi:10.1148/radiology.211.2.r99ma46549
- Abrams, 1995, Diagnostic utility of contrast echocardiography and lung perfusion scan in patients with hepatopulmonary syndrome, Gastroenterology, 109, 1283, 10.1016/0016-5085(95)90589-8 · doi:10.1016/0016-5085(95)90589-8
- Wolfe, 1977, Hypoxemia of cirrhosis: detection of abnormal small pulmonary vascular channels by a quantitative radionuclide method, Am J Med, 63, 746, 10.1016/0002-9343(77)90161-9 · doi:10.1016/0002-9343(77)90161-9
- Kalambokis, 2010, Pitfalls in the assessment of intrapulmonary shunt using lung perfusion scintigraphy in patients with cirrhosis, Liver Int, 31, 138, 10.1111/j.1478-3231.2010.02330.x · doi:10.1111/j.1478-3231.2010.02330.x
- Kochar, 2011, Serial pulse oximetry in hepatopulmonary syndrome, Dig Dis Sci, 56, 1862, 10.1007/s10620-011-1600-7 · doi:10.1007/s10620-011-1600-7
- Tanikella, 2008, Pilot study of pentoxifylline in hepatopulmonary syndrome, Liver Transpl, 14, 1199, 10.1002/lt.21482 · doi:10.1002/lt.21482
- Gupta, 2008, Pentoxyfylline therapy for hepatopulmonary syndrome: a piloto study, Arch Intern Med, 168, 1820, 10.1001/archinte.168.16.1820 · doi:10.1001/archinte.168.16.1820
- De, 2010, The role of garlic in hepatopulmonary syndrome: a randomized controlled trial, Can J Gastroenterol, 24, 183, 10.1155/2010/349076 · doi:10.1155/2010/349076
- Tsauo, 2015, Role of transjugular intrahepatic portosystemic shunts in the management of hepatopulmonary syndrome: a systemic literature review, J Vasc Interv Radiol, 26, 1266, 10.1016/j.jvir.2015.04.017 · doi:10.1016/j.jvir.2015.04.017
- Poterucha, 1995, Failure of hepatopulmonary syndrome to resolve after liver transplantation and successful treatment with embolotherapy, Hepatology, 21, 96, 10.1002/hep.1840210117 · doi:10.1002/hep.1840210117
- Fallon, 2006, Model for end-stage liver disease (MELD) exception for hepatopulmonary syndrome, Liver Transpl, 12, S105, 10.1002/lt.20971 · doi:10.1002/lt.20971
- Fleming, 2008, Hepatopulmonary syndrome use of extracorporeal life support for life-threatening hypoxia following liver transplantation, Liver Transpl, 14, 966, 10.1002/lt.21477 · doi:10.1002/lt.21477
- Monsel, 2011, Extracorporeal membrane oxygenation as a brifge to liver trnsplantation for acute respiratory distress syndrome-induced life-threatening hypoxemia aggravated by hepatopulmonary syndrome, Crit Care, 15, R234, 10.1186/cc10476 · doi:10.1186/cc10476
- Chihara, 2011, Immediate nonivasive ventilation may improve mortality in patients with hepatopulmonary syndrome after liver transplantation, Liver Transpl, 17, 44, 10.1002/lt.22207 · doi:10.1002/lt.22207
- Torregrosa, 2001, Role of Doppler echocardiography in the assessment of portopulmonary hypertension in liver transplantation candidates, Transplantation, 71, 572, 10.1097/00007890-200102270-00015 · doi:10.1097/00007890-200102270-00015
- Cotton, 2002, Role of echocardiography in detecting portopulmonary hypertension in liver transplant candidates, Liver Transpl, 8, 1051, 10.1053/jlts.2002.35554 · doi:10.1053/jlts.2002.35554
- Paulus, 2013, Oestrogen and sexual Dimorphism of pulmonary arterial hypertension; a transitional challenge, Eur Respir J, 41, 1014, 10.1183/09031936.00021713 · doi:10.1183/09031936.00021713
- Condino, 2005, Portopulmonary hypertension in pediatric patients, J Pediatr, 147, 20, 10.1016/j.jpeds.2005.02.019 · doi:10.1016/j.jpeds.2005.02.019
- Ricci, 2007, Assessment of acute pulmonary vascular reactivity in portopulmonary hypertension, Liver Transpl, 13, 1506, 10.1002/lt.21173 · doi:10.1002/lt.21173
- Halank, 2004, Use of oral endothelin-receptor antagonist bosentan in the treatment of portopulmonary hypertension, Transplantation, 77, 1775, 10.1097/01.TP.0000122420.86904.89 · doi:10.1097/01.tp.0000122420.86904.89
- Cadden, 2009, The use of sildenafil to treat portopulmonary hypertension prior to liver transplantation, Ann Hepatol, 8, 158, 10.1016/S1665-2681(19)31798-3 · doi:10.1016/s1665-2681(19)31798-3
- Fisher, 2015, Effectiveness of phosphodiesterase-5 inhibitor therapy for portopulmonary hypertension, Can Respir J, 22, 42, 10.1155/2015/810376 · doi:10.1155/2015/810376
- Tzathas, 2002, Sildenafil (viagra) is a risk factor for acute variceal bleeding, Am J Gastroenterol, 97, 1856, 10.1111/j.1572-0241.2002.05876.x · doi:10.1111/j.1572-0241.2002.05876.x
- Sussman, 2006, Successful liver transplantation following medical management of portopulmonary hypertension: a single-center series, Am J Transplant, 6, 2177, 10.1111/j.1600-6143.2006.01432.x · doi:10.1111/j.1600-6143.2006.01432.x
- Melgosa, 2010, Acute and long-term effects of inhaled iloprost in portopulmonary hypertension, Liver Transpl, 16, 348, 10.1002/lt.21997 · doi:10.1002/lt.21997
- Colombato, 1996, Haemodynamic adaptation two months after transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients, Gut, 39, 600, 10.1136/gut.39.4.600 · doi:10.1136/gut.39.4.600
- Yoshida, 1993, Single-lung vs. liver transplantation for the treatment of portopulmonary hypertension–a comparison of two patients, Transplantation, 55, 688
- Mangus, 2013, Mild to moderate pulmonary hypertension in liver transplantation, J Surg Res, 184, 1150, 10.1016/j.jss.2013.04.040 · doi:10.1016/j.jss.2013.04.040
- Ramsay, 1997, Severe pulmonary hypertension in liver transplant candidates, Liver Transpl Surg, 3, 494, 10.1002/lt.500030503 · doi:10.1002/lt.500030503
- Krowka, 2006, Model for end-stage liver disease (MELD) exception for portopulmonary hypertension, Liver Transpl, 12, S114, 10.1002/lt.20975 · doi:10.1002/lt.20975
- Ramsay, 2010, Portopulmonary hypertension and right heart failure in patients with cirrhosis, Curr Opin Anaesthesiol, 23, 145, 10.1097/ACO.0b013e32833725c4 · doi:10.1097/aco.0b013e32833725c4
- Paulsen, 1989, Considerations for anesthetic management during veno-venous bypass in adult hepatic transplantation, Anesth Analg, 68, 489, 10.1213/00000539-198904000-00012 · doi:10.1213/00000539-198904000-00012
- Stratta, 2013, Extracorporeal membrane oxygenation rescue therapy in a case of portopulmonary hypertension during liver transplantation: a case report, Transplant Proc, 45, 2774, 10.1016/j.transproceed.2013.07.001 · doi:10.1016/j.transproceed.2013.07.001
- Khaderi, 2014, Long-term follow-up of portopulmonary hypertension patients after liver transplantation, Liver Transpl, 20, 724, 10.1002/lt.23870 · doi:10.1002/lt.23870
Cited by
Ginès, P., Krag, A., Abraldes, J. G., Solà, E., Fabrellas, N., & Kamath, P. S. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01374-x · Cited by 1,663
Self-citationEASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
Sangro, B., Argemi, J., Ronot, M., Paradis, V., Meyer, T., Mazzaferro, V., Jepsen, P., Golfieri, R., Galle, P., Dawson, L., et al. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2024.08.028 · Cited by 985
Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study
Tapper, E. B., & Parikh, N. D. (2018) · BMJ · doi:10.1136/bmj.k2817 · Cited by 856
Biggins, S. W., Angeli, P., Garcia‐Tsao, G., Ginès, P., Ling, S. C., Nadim, M. K., Wong, F., & Kim, W. R. (2021) · Hepatology · doi:10.1002/hep.31884 · Cited by 846
Self-citationManagement of Hepatocellular Carcinoma: A Review
Brown, Z. J., Tsilimigras, D. I., Ruff, S. M., Mohseni, A., Kamel, I. R., Cloyd, J. M., & Pawlik, T. M. (2023) · JAMA Surgery · doi:10.1001/jamasurg.2022.7989 · Cited by 763
Metadata
- Authors
- Angeli, P., Bernardi, M., Villanueva, C., Francoz, C., Mookerjee, R. P., Trebicka, J., Krag, A., Laleman, W., & Gines, P.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2018-08
- Volume
- 69
- Issue
- 2
- Pages
- 406-460
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2802906787
- Cited by
- 2,905
- References
- 479
- FWCI
- 132.14
- Type
- journal article
- Language
- en
- Update notices
- erratum (2018-11-01)
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.